Treace Medical Concepts, Inc. is a medical technology company. It is advancing the standard of care for the surgical management of bunion and related midfoot deformities. It has patented the Lapiplasty 3D Bunion Correction System a combination of instruments, implants, and surgical methods designed to surgically correct all three planes of the bunion deformity and secure the unstable joint, addressing the root cause of the bunion and helping patients get back to their active lifestyles. It has Adductoplasty Midfoot Correction System, designed for reproducible surgical correction of midfoot deformities, the SpeedMTP Rapid Compression Implant for addressing bunions through big toe joint fusions, and two systems for minimally invasive osteotomy surgeries: the Nanoplasty 3D Minimally Invasive Bunion Correction System and the Percuplasty Percutaneous 3D Bunion Correction System. It sells its products to physicians, surgeons, ambulatory surgery centers, hospitals, and stocking distributors.
종목 코드 TMCI
회사 이름Treace Medical Concepts Inc
상장일Apr 23, 2021
CEOTreace (John T)
직원 수477
유형Ordinary Share
회계 연도 종료Apr 23
주소100 Palmetto Park Place
도시PONTE VEDRA
증권 거래소NASDAQ OMX - NASDAQ BASIC
국가United States of America
우편 번호32081
전화19043735940
웹사이트https://www.treace.com/
종목 코드 TMCI
상장일Apr 23, 2021
CEOTreace (John T)
지난 5년 동안 총
0.00
USD의 배당금이 분배되었습니다.

데이터 없음